Lsl Pharma Group Inc (LSL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 346 | 334 | 244 | 347 | 289 |
| Accounts receivable | 221 | -728 | N/A | -247 | 93 |
| Other Working Capital | -713 | -2,423 | -474 | -2,439 | 368 |
| Other Operating Activity | 39 | 907 | -735 | -88 | -741 |
| Operating Cash Flow | $-107 | $-1,910 | $-964 | $-2,427 | $9 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -929 | -543 | 854 | -186 | -230 |
| Net Acquisitions | -2,105 | N/A | N/A | 0 | 0 |
| Purchase Sale Intangibles | -203 | -146 | -311 | -25 | 0 |
| Other Investing Activity | 0 | 0 | 114 | 0 | -10 |
| Investing Cash Flow | $-3,237 | $-689 | $657 | $-211 | $-240 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -505 | 530 | -578 | 851 | -78 |
| Debt Issued | 438 | 728 | 659 | 2,087 | 835 |
| Debt Repayment | -382 | -440 | 926 | -165 | -276 |
| Common Stock Issued | 5,285 | 1,985 | 0 | 0 | 0 |
| Other Financing Activity | -1,170 | -245 | -663 | -680 | -481 |
| Financing Cash Flow | $3,666 | $2,558 | $344 | $2,093 | $0 |
| Beginning Cash Position | -33 | 8 | -29 | 515 | 746 |
| End Cash Position | 289 | -33 | 8 | -30 | 515 |
| Net Cash Flow | $322 | $-41 | $37 | $-545 | $-231 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107 | -1,910 | -964 | -2,427 | 9 |
| Capital Expenditure | -1,132 | -689 | N/A | -211 | -230 |
| Free Cash Flow | -1,239 | -2,599 | -964 | -2,638 | -221 |